By Iain Gilbert
Date: Friday 07 Mar 2025
(Sharecast News) - Life sciences firm Avacta revealed on Friday that it has agreed to sell its UK-based diagnostics unit to Duomed Belgium for £12.9m in cash.
By Josh White
Date: Thursday 16 Jan 2025
(Sharecast News) - Avacta Therapeutics announced promising results from its ongoing phase 1a trial of AVA6000 on Thursday, demonstrating meaningful tumour shrinkage in patients with salivary gland cancer (SGC).
By Michele Maatouk
Date: Thursday 21 Nov 2024
(Sharecast News) - Peel Hunt initiated coverage on Avacta on Thursday with a 'buy' rating and 99p price target as it pointed out three key aspects of the investment case.
Currency | UK Pounds |
Share Price | 35.33p |
Change Today | 2.83p |
% Change | 8.72 % |
52 Week High | 82.50 |
52 Week Low | 31.00 |
Volume | 1,674,028 |
Shares Issued | 386.87m |
Market Cap | £136.69m |
RiskGrade | 461 |
Value |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Price Trend |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Income | ![]() |
---|
Growth |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Strong Buy | 2 |
Buy | 1 |
Neutral | 0 |
Sell | 0 |
Strong Sell | 0 |
Total | 3 |
No dividends found |
Time | Volume / Share Price |
15:13 | 2,929 @ 34.15p |
15:12 | 34,000 @ 34.72p |
15:10 | 5,000 @ 34.80p |
15:05 | 1,055 @ 34.70p |
14:48 | 432 @ 34.72p |
You are here: research